top of page
Search


GAMP 5 Category 4: Guide for Configured Systems 2026
Validating a configured system shouldn't feel like building a custom platform from scratch, yet many life science firms still treat GAMP 5 category 4 validation like a Category 5 project. It's frustrating to watch your project timelines slip because your team is over-validating standard features or...
1 hour ago


Pharma CMMS Implementation: Validated 2026 Roadmap
What if the manual paper logs you maintain for security are actually the greatest liability in your next regulatory audit? Most maintenance teams recognize that cumbersome manual transcription invites human error, yet the fear of software updates breaking a validated system often keeps innovation at...
3 days ago


Computer System Validation Consultant: A Strategic Guide to GxP Compliance in 2026
Did you know that in 2024, over 65% of GMP inspection findings in Europe were linked to data integrity and computerized system gaps? It's a sobering statistic that highlights the growing complexity of the regulatory environment. You've likely felt the frustration of validation projects that drag on...
5 days ago


EMPOWER CDS Validation Services: The 2026 Guide to GxP Compliance
Could your "tried and true" manual integration methods actually be the biggest red flag during your next FDA inspection? Many lab managers feel the constant weight of configuring complex user privileges and the fear that a resource-heavy validation project will stall productivity for months. It's a...
Sep 8


EQMS Validation for Medical Devices: GAMP 5 Guide 2026
The transition to the FDA Quality Management System Regulation (QMSR) on February 2, 2026, fundamentally changed the compliance landscape. If you're still relying on traditional, document-heavy eQMS validation for medical devices to satisfy these new requirements, you're likely facing ballooning cos...
Sep 5


Data Integrity Remediation Plan: A Strategic Framework for Pharma Compliance in 2026
In fiscal year 2025, the FDA issued 303 warning letters, a 59% increase from the previous year. This surge reflects a regulatory environment that's becoming more precise and less forgiving, particularly regarding how data is captured and stored. You've likely felt the mounting pressure of managing h...
Sep 3


Common FDA 483 Observations for Data Integrity: Examples and Remediation in 2026
Did you know that data integrity has remained the most cited category for FDA citations for six consecutive years, climbing to 91 observations per 100 pharmaceutical inspections? It's understandable why anxiety over audit trail gaps and common FDA 483 observations data integrity issues keeps many qu...
Sep 1


How to Prepare for an FDA Inspection: A 2026 Compliance Checklist
An FDA investigator walks through your front door and asks to see the complete audit trail for a batch released two years ago. If that request triggers panic about document retrieval or data integrity gaps, you're facing a challenge shared by many quality leaders. Learning how to prepare for an FDA...
Aug 28
bottom of page
